To further identify the specific interaction site between ANGPTL2 and VPS33B, we examined their potential binding capacities with different ANGPTL2 mutations at the C-terminal region (aa247-aa471) that occur frequently in human cancers, as revealed by public data settings (such as the Catalogue of Somatic Mutations in Cancer, COSMIC). This evidence concerns the gene ANGPTL2 and cancer.